Developmental Pilot Grants
The Johns Hopkins NIMH Center offers Development Core Pilot Awards for innovative projects focused on the neurological complications of HIV infection. One of the center’s main objectives is funding new investigators (including cross-disciplinary faculty) interested in collaborating with the center faculty to generate preliminary data that will lead to future NIMH funding addressing the neurological complications of HIV infection.
Four pilot grants of up to $24,000 in direct costs for a one-year period will be awarded.
Who Should Apply
All JHU faculty and postdoctoral fellows and faculty members are encouraged to apply. Fellows seeking funds for a project indirectly related to their mentor's research (i.e. trying to start an independent line of investigation) are also encouraged to apply. If the senior investigator has funding for the same proposed project, such a pilot proposal would be considered non-responsive application.
Proposal Guidelines
The need is urgent for innovative approaches to address in people with HIV-1 infection (PWH) the neurological and neuropsychiatric complications and viral reservoirs in the central nervous system.
The Center is interested in proposals that:
- Use clinical data and biospecimens from phenotyped cohorts available through the JH CAHN and/or institutional partners (see graphic)
- Address fundamental biology related to HIV-CNS neuropathogenesis and when possible linking to the principles of Research Domain Criteria (RDoc)
- Preclinical drug discovery research on cellular pathways with druggable molecular targets implicated in HIV-neuropathogenesis
How to Apply
Application due date: January 12, 2026
Application requirements
- The application should be 6-pages maximum in the NIH, R21 format, detailing:
- specific aims
- significance
- innovation
- approach (including preliminary data, if any)
- A Rigor and Reproducibility section as required by the NIH. See NIH guidance for this section.
- Not included in the 6-page maximum:
- Investigator’s NIH biosketch
- Project budget ($24,000 max)
Proposals are accepted through the MyPeerReview online platform. See instructions for submitting your application (PDF).
Contacts
Please contact us with any questions or to discuss your project:
- Co-Director: Dr. Ahmet Hoke ([email protected], 410-955-2227)
- Co-Director: Dr. Amanda Brown ([email protected]; 410-614-2429)
Scoring Criteria
- Scientific merit, including feasibility and experimental design (10 points). Well controlled experiments with convincing or proven methodologies; clearly and appropriately related to the Specific Aims and individual hypotheses; useful information likely to be generated whether the hypothesis is supported or rejected by experimental results. Adequate discussion of statistical issues. Potential problems identified and suitable alternative approaches outlined in convincing detail.
- Scientific impact and novelty (8 points). To receive full score, the proposal should have: major new implications for therapeutics or direct patient care, AND/OR represent a major departure from the established paradigms in the literature, AND/OR potentially answer a major unsolved problem or question in the indicated field(s) involved. Novelty and impact can derive from the first application of new techniques or disciplines to preexisting problems (an example from the past would be the first MRI brain studies of HIV-associated dementia or a new animal model of HIV CNS disease).
Bonus points:
- PI new to NeuroHIV research (4 points)
- New collaboration between JHU investigators (2 point)
- Proposal is utilizing JH CAHN resources with a focal point on Research Domain Criteria (RDoc) (1 point)
All proposals must conform to the requirements of feasible and rigorous experimental design. Routine studies that follow long-established lines of investigation in a given discipline will not be considered responsive.
Funding Decision
Internal funding decision will be made by January 30, 2026. Funded grants are subject to final approval from the NIMH Program Officer and Grants Manager. The expected project start dates vary, ranging from one to two months after the internal funding decision date. We are aiming for the March 1, 2026 start date.
Other Considerations if Your Grant Receives a Fundable Score
After the JH CAHN scientific review process, if your pilot grant is considered for funding, additional research compliance documents will be required:
-
If your proposed research needing Institutional Review Board (IRB) or Animal Care Use Committee (ACUC) approval, be sure you have completed all compliance training and preferably have the relevant protocol already approved. If a protocol must be submitted for review and approval, understand that your project start date will be delayed.
-
Review of all pilot grant by the JH CAHN’s NIMH Program Officer is required before any research can commence. This process can take one to several weeks.
Past Pilot Grant Awardees
-
- Huijun Jack Wei, PhD
Title: “Development of novel neutral Sphingomyelinase 2 (nSMase2) inhibitor as a novel therapeutic approach for HIV-Associated Cognitive Disorders (HAND)” - Lindsay Hayes, PhD
Title: “Isolation of brain-derived myeloid cells in NeuroHIV“ - Run-Duo Gao, PhD
Title: “Development of a novel sigma-1 receptor agonist with the potential to improve cognitive function in HAND” - Sandeepa Sur, PhD
Title: “Quantitative Susceptibility Mapping of Brain Iron Content: Mechanistic Links to Neuropsychiatric symptoms and Cognitive Impairment in People with HIV”
- Huijun Jack Wei, PhD
-
- Benjamin Bell, PhD
Title: “Evaluation of impact and treatment effect on sleep disturbances in two murine models of HAND” - Pragney Deme, PhD
Title: Serum metabolic changes associated with HIV infection before and after ART; relationship to cognitive status in people living with HIV in Uganda - Cory White, PhD
Title: “Determining the consequences of HIV-infection and antiretroviral therapies on lipid metabolism in the central nervous system” - Jinchong Xu, PhD
Title: “Microglia Assembled Human Brain Organoids to Evaluate the Combined Antiviral Therapy”
- Benjamin Bell, PhD
-
- Yiyao Huang, MD
Title: “Noncoding RNA regulation and release in SIV-infected brain” - Rana Rais, PhD
Title: “Pharmacokinetic evaluation of proprietary neutral-spinghomyelinase-2 (nSMase2) inhibitors in non-human primates” - Rebecca Veenhuis, PhD
Title: “The relationship between the size of the HIV latent reservoir in CD4 T cells and monocytes and risk for CNS dysfunction in virally suppressed HIV+ women”
- Yiyao Huang, MD
-
- Carlo Colantuoni, PhD
Title: "iPSC-Derived Neural Systems to Explore HIV-Associated Cognitive Impairment (HIV-CI)" - Leah Rubin, PhD, MPH
Title: "Soluble and cellular immune activation and inflammation markers in detrimental cognitive change despite suppression of plasma RNA in HIV-infected women" - Michael Nedelcovych, PhD
Title: "Glutamine Antagonism as a Novel Therapeutic Approach for HIV-Associated Neurocognitive Disorders (HAND)" - Seung Wan Yoo, PhD
Title: "Inhibition of HIV replication with novel small molecule inhibitors of neutral sphingomyelinase 2" - Tory Johnson, PhD
Title: "Detecting Tat from human serum samples"
- Carlo Colantuoni, PhD
-
- Charlene Gamaldo, M.D., FAASM, FAAN
Title: “The Application of Mobile Health Technology as an Effective Tool to Improve the Sleep Health Care of Seropositive HIV Individuals” - Takashi Tsukamoto, Ph.D.
Title: “Preclinical evaluation of the therapeutic utility of system xc- inhibition in HAND” - Charles Bailey, DVM Dipl. ACVP
Title: “TREM2 in the Macaque Model of HAND: Determining the Role of TREM2 in HIV-associated Neurocognitive Disorders” - Camilo Rojas, Ph.D.
Title: ” Identification of Inhibitors of Serine Palmitoyl Transferase to Use as Chemical Probes in Models of HAND”
- Charlene Gamaldo, M.D., FAASM, FAAN
-
- Kelly Pate, D.V.M., Ph.D.
Research Study Title: "A mouse model of the role of platelets in the establishment of latent viral reservoirs" - Rana Rais, Ph.D.
Research Study Title: "Evaluation of system xc- inhibition in preclinical models of neuroAIDS" - Camilo Rojas, P.hD.
Research Study Title: "Inhibition of neutral sphingomylinase 2 for the treatment of HAND" - David Graham, Ph.D.
Research Study Title: "The study of simian immunodeficiency virus (SIV) pathogenesis in pigtailed and rhesus monkeys"
- Kelly Pate, D.V.M., Ph.D.
-
Cherie Marvel, Ph.D.
Research Study Title: "Examining the role of attentional bias on risk taking behavior in HIV-positive patients" -
- Shilpa Buch, Ph.D.
Research Study Title: "Role of endoplasmis reticulum stress in HIV Tat and cocaine-mediated cooperative activation of astrocytes: implications for HAND" - Ekaterina Dadachova, Ph.D.
Research Study Title: "Elimination of HIV in CNS with armed antibodies to gp41 glycoprotein" - Kenneth Witwer, Ph.D.
Research Study Title: "Development of miRNA-based therapies to silence or purge the latent macrophase reservoir in HAND"
- Shilpa Buch, Ph.D.
-
21 additional pilot grants were awarded during those years that significantly contributed to the continued research success of its grantees and the JHU NIMH Center.